Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics - Top-Institutions - MDSpire

Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics

  • By

  • Yuki Noriyama

  • Shintaro Araki

  • Ryohei Takada

  • Hiroaki Fukui

  • Yuya Honda

  • Kazuki Okumura

  • Yuki Nishi

  • Minobu Ikehara

  • Takashi Okada

  • May 5, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Nara Medical University Hospital
    Nara Medical University Hospital

    Nara, Nara

    Key Differentiators

    • Psychiatry

  • #2

    university hospital in Japan
    university hospital in Japan

    Unknown, Unknown

    Key Differentiators

    • Psychiatry

  • #3

    Sunnybrook Health Sciences Centre
    Sunnybrook Health Sciences Centre

    Toronto, Ontario

    Key Differentiators

    • Psychiatry

Original Source(s)

Real-world use of brexpiprazole during inpatient treatment for schizophrenia: continuation, discontinuation, and concomitant psychotropics

  • by Yuki Noriyama, Shintaro Araki, Ryohei Takada, Hiroaki Fukui, Yuya Honda, Kazuki Okumura, Yuki Nishi, Minobu Ikehara, Takashi Okada

  • May 5, 2026

Related Content

The Tango of Immune and Neural Cells: Orchestrating Neuroinflammation Mediated Brain Disorders

Improving care for cognitive impairment in schizophrenia: current perspectives and opportunities in Portugal (a consensus development conference)

Artificial intelligence approaches for schizophrenia prediction and its biomarkers using medical imaging data